Alphatec Holdings, Inc.
ATECMedical Devices
$11.37−0.70%As of Oct 29vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- –
- P/E (FY1)
- 34.9×
- From 52W high
- −49.87%
- EPS (LTM)
- -$0.56
- Revenue (LTM)
- $839.7M
- Net margin
- -10.35%
- Dividend yield
- 0.00%
Nomior Score
41
Steady ProfileSpeculativeBottom 31% of the scored universe
Growth83
Quality52
Value50
Momentum11
Resilience33
Growth
+22.81%revenue a year over 9 fiscal years
FY16 $120.2MLTM $839.7M
Connections
Revenue to profitQ3 FY26
The net loss was 2% of revenue, narrower by 12 pts on a year.
Latest resultsThird Quarter 2026
- Revenue
- $221 million
Total revenue grew year-over-year, led by strong surgical growth in hardware and procedure volumes and new surgeon adoption. Management said third-quarter revenue fell short of its expectations mainly because of lower biologics attachment, and it made improving biologics performance a clear priority. The company also updated its full-year outlook for total revenue, adjusted EBITDA and free cash flow.
Who owns it
2funds, 1 tracked portfolio